Dr. Larry Herman
Opiate use disorders (OUD) are a major and increasing cause of morbidity and mortality in the United States. Medications for addiction treatment (MAT), such as methadone and buprenorphine, have been shown to be the most effective treatments for OUD, but only ten percent of people with OUD are in treatment using these medications. This paper identifies the most common barriers to initiation and retention of MAT, such as stigma, poor insurance coverage, lack of education and training, limited transportation, and legal involvement. This paper also suggests solutions to these problems.
Mohr M. Barriers to Entry and Retention for Medications for Addiction Treatment for Opioid Use Disorders. Lynchburg Journal of Medical Science. 2022; 4(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.